» Articles » PMID: 35682030

Inverse Association Between Omega-3 Index and Severity of COVID-19: A Case-Control Study

Abstract

Background: Omega-3 fatty acids enhance immune response and modulate inflammation. This study aimed to determine the relationship between omega-3 fatty acid status and the severity of SARS-CoV-2 infection. Methods: Using a case−control design, we compared hospitalized patients with severe SARS-CoV-2 infection (cases, n = 73) with a group of ambulatory patients with mild SARS-CoV-2 infection (controls, n = 71). No patients were vaccinated against SARS-CoV-2. Results: The cases were older (p = 0.003), less educated (p = 0.001), had larger neck and smaller waist circumferences (p = 0.035 and p = 0.003, respectively), more frequently had diabetes (p < 0.001), consumed less fish (p < 0.001), consumed higher proportions of fried fish (p = 0.001), and had lower Omega-3 Index (O3I) values (p = 0.001) than controls. Cases had significantly lower rates of upper airway symptoms than controls. Lower O3I was associated with an increased likelihood of developing severe COVID-19 after adjusting for potential confounders (OR: 0.52; CI 0.32−0.86). Diabetes (OR: 4.41; CI 1.60−12.12), neck circumference (OR: 1.12; CI 1.03−1.21), and older age (OR: 1.03; CI 1.002−1.062) were also linked to COVID-19 severity. Fried fish consumption and low educational level were independent risk factors for severe COVID-19. Conclusions: This study suggests incorporating nutritional interventions to improve omega-3 status within nonpharmacological measures may help to reduce the severity of COVID-19.

Citing Articles

Precision nutrition to reset virus-induced human metabolic reprogramming and dysregulation (HMRD) in long-COVID.

Naidu A, Wang C, Rao P, Mancini F, Clemens R, Wirakartakusumah A NPJ Sci Food. 2024; 8(1):19.

PMID: 38555403 PMC: 10981760. DOI: 10.1038/s41538-024-00261-2.


Risk of secondhand smoke exposure and severity of COVID-19 infection: multicenter case-control study.

Kishore S, Shah V, Bera O, Venkatesh U, Kakkar R, Aggarwal P Front Public Health. 2023; 11:1210102.

PMID: 37601179 PMC: 10435989. DOI: 10.3389/fpubh.2023.1210102.


Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection.

Chen P, Wu M, He Y, Jiang B, He M Signal Transduct Target Ther. 2023; 8(1):237.

PMID: 37286535 PMC: 10244875. DOI: 10.1038/s41392-023-01510-8.


Potential Benefits of Omega-3 Polyunsaturated Fatty Acids (N3PUFAs) on Cardiovascular Health Associated with COVID-19: An Update for 2023.

Lu L, Quek S, Lu S, Chen J Metabolites. 2023; 13(5).

PMID: 37233671 PMC: 10222821. DOI: 10.3390/metabo13050630.


Association between blood N-3 fatty acid levels and the risk of coronavirus disease 2019 in the UK Biobank.

Harris W, Tintle N, Perinkulam Sathyanarayanan S, Westra J Am J Clin Nutr. 2023; 117(2):357-363.

PMID: 36863828 PMC: 9972865. DOI: 10.1016/j.ajcnut.2022.11.011.


References
1.
Calder P . Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochem Soc Trans. 2017; 45(5):1105-1115. DOI: 10.1042/BST20160474. View

2.
Voysey M, Clemens S, Madhi S, Weckx L, Folegatti P, Aley P . Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2020; 397(10269):99-111. PMC: 7723445. DOI: 10.1016/S0140-6736(20)32661-1. View

3.
Hodgson S, Mansatta K, Mallett G, Harris V, Emary K, Pollard A . What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2. Lancet Infect Dis. 2020; 21(2):e26-e35. PMC: 7837315. DOI: 10.1016/S1473-3099(20)30773-8. View

4.
Schultze J, Aschenbrenner A . COVID-19 and the human innate immune system. Cell. 2021; 184(7):1671-1692. PMC: 7885626. DOI: 10.1016/j.cell.2021.02.029. View

5.
Merino J, Joshi A, Nguyen L, Leeming E, Mazidi M, Drew D . Diet quality and risk and severity of COVID-19: a prospective cohort study. Gut. 2021; 70(11):2096-2104. PMC: 8500931. DOI: 10.1136/gutjnl-2021-325353. View